20 Sep ChromaDex Appoints Ozan Pamir as Chief Financial Officer
LOS ANGELES--(BUSINESS WIRE)--$CDXC #CFO--ChromaDex Corp. (NASDAQ:CDXC), the global authority on nicotinamide adenine dinucleotide (NAD+) research with a focus on healthy aging, announces the appointment of Ozan Pamir as Chief Financial Officer. Mr. P...